These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10851066

  • 21. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
    Lin MF, Lee MS, Garcia-Arenas R, Lin FF.
    Cell Biol Int; 2000; 24(10):681-9. PubMed ID: 11023645
    [Abstract] [Full Text] [Related]

  • 22. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
    Wells A, Souto JC, Solava J, Kassis J, Bailey KJ, Turner T.
    Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
    [Abstract] [Full Text] [Related]

  • 23. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
    Murillo H, Schmidt LJ, Tindall DJ.
    Cancer Res; 2001 Oct 15; 61(20):7408-12. PubMed ID: 11606371
    [Abstract] [Full Text] [Related]

  • 24. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
    Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ.
    Oncogene; 2004 Mar 18; 23(12):2197-205. PubMed ID: 14767470
    [Abstract] [Full Text] [Related]

  • 25. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B, Mayer D.
    Int J Oncol; 2008 Sep 18; 33(3):623-9. PubMed ID: 18695894
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
    Zoubeidi A, Rocha J, Zouanat FZ, Hamel L, Scarlata E, Aprikian AG, Chevalier S.
    Mol Cancer Res; 2009 Jan 18; 7(1):142-55. PubMed ID: 19147545
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT, Wang X, Lee DT, Tam PC, Tsao SW, Wong YC.
    Carcinogenesis; 2004 Apr 18; 25(4):517-25. PubMed ID: 14688027
    [Abstract] [Full Text] [Related]

  • 32. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A, Di Domenico M, Castoria G, Nanayakkara M, Lombardi M, de Falco A, Bilancio A, Varricchio L, Ciociola A, Auricchio F.
    Cancer Res; 2005 Nov 15; 65(22):10585-93. PubMed ID: 16288052
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
    Nagasawa J, Mizokami A, Koshida K, Yoshida S, Naito K, Namiki M.
    Int J Urol; 2006 May 15; 13(5):587-92. PubMed ID: 16771730
    [Abstract] [Full Text] [Related]

  • 36. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 15; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 37. Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.
    Griffiths K, Morton MS, Nicholson RI.
    Eur Urol; 1997 Aug 15; 32 Suppl 3():24-40. PubMed ID: 9267783
    [Abstract] [Full Text] [Related]

  • 38. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
    Lin MF, Meng TC, Rao PS, Chang C, Schonthal AH, Lin FF.
    J Biol Chem; 1998 Mar 06; 273(10):5939-47. PubMed ID: 9488733
    [Abstract] [Full Text] [Related]

  • 39. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
    Lee MS, Igawa T, Lin MF.
    Oncogene; 2004 Apr 15; 23(17):3048-58. PubMed ID: 14990987
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.